GeneDx Holdings Corp.
WGS
$86.48
$0.610.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.74M | -63.32M | -17.67M | -7.64M | 10.81M |
| Total Depreciation and Amortization | 6.71M | 6.81M | 5.98M | 6.47M | 6.19M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.68M | 47.26M | 8.33M | 19.80M | 9.76M |
| Change in Net Operating Assets | -22.64M | -23.16M | 262.00K | -2.87M | -16.34M |
| Cash from Operations | -28.98M | -32.41M | -3.09M | 15.77M | 10.42M |
| Capital Expenditure | -10.11M | -6.45M | -4.35M | -6.17M | -2.37M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 339.00K | 0.00 | -33.20M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.48M | -10.80M | -7.06M | 1.49M | -786.00K |
| Cash from Investing | -5.63M | -17.26M | -11.07M | -4.69M | -36.35M |
| Total Debt Issued | -299.00K | 97.00M | -- | -- | -13.89M |
| Total Debt Repaid | -489.00K | -58.94M | -682.00K | -1.22M | -853.00K |
| Issuance of Common Stock | 1.79M | 534.00K | 23.88M | 11.98M | 15.09M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.01M | 38.59M | 23.19M | 10.77M | 346.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -33.61M | -11.07M | 9.03M | 21.85M | -25.58M |